Global | Coronavirus Watch: The limits of vaccines
Vaccines are the key to a safe and permanent transition to more normal conditions. But evidence from economies that already have implemented widespread vaccine rollouts confirms our long-held view that high vaccination rates will not be the sole factor.
Of the 20 economies that have delivered the swiftest rollouts, nine are small states with patchy data. Of the remaining 11, only five now have lower daily Covid cases than they did at the point they began vaccinations. On mortality rates, the equivalent figure is just six.
Lockdown stringency scores suggest an over-eagerness to lift restrictions has not necessarily been the reason for the worsening health situation in some of these economies. Also, the presence of several new variants in the UK, US, and Israel, which have recorded large falls in cases and deaths this year, suggests the spread of variants isn’t solely to blame.
Estimates that the first dose of the Sinopharm vaccine may be just 3% effective in preventing infection could explain why some economies have seen high vaccine take-up but surging cases. And new variants may have reduced the efficacy of some individual vaccines, also lowering immunity.
In all, the experiences of economies such as Israel provides grounds for optimism. But at the same time, developments in other economies show that a corner will not be turned simply by reaching a specific vaccine threshold.
Tags:
Related Services

Post
Trump’s tariffs on Canada would raise regional commodity prices
A blanket 25% tariff on Canadian imports to the US could have a significant impact on commodity prices, squeeze profit margins of Canadian exporters and raise prices for US end-users.
Find Out More
Post
Chinese policy is unlikely to shift due to announced tariffs
US President Donald Trump's announcement of an additional 10% tariff on imports from China was in line with our baseline expectation. But the immediacy of implementation, the blanket style of tariffs, and the inclusion of stronger language around retaliation in policy documents still add significant uncertainty to our forecasts.
Find Out More